What it's actually good for
An HRV biofeedback device — an ear-clip or chest-strap sensor paired with an app — measures the beat-to-beat timing of your heartbeat and displays it in real time so you can see, second by second, whether your breathing is calming your nervous system or not. The training goal isn't a bigger HRV number for its own sake; it's learning to breathe at your personal resonance frequency, usually around six breaths per minute, which maximizes the natural rise and fall of heart rate with each breath and appears to exercise the baroreflex the way strength training exercises a muscle. HeartMath's version of this (branded "coherence") and the more clinical "resonance-frequency" protocol from Lehrer and colleagues are the same underlying mechanism with different marketing.
This is a stress-management tool, not a general health device. The evidence is genuinely good for anxiety and subjective stress. It is not good enough yet to justify claims about preventing heart disease or reliably lowering blood pressure.
What the research says
Anxiety and psychological well-being (Grade B). The best summary evidence is a 2020 systematic review and meta-analysis that screened 1,868 papers down to 58 qualifying RCTs and found a significant small-to-moderate effect favoring HRV biofeedback, with the largest effects on anxiety, depression, and anger, and the weakest on PTSD, sleep, and quality of life. "Small to moderate" and inconsistent across specific conditions is exactly why this is a B rather than an A — the direction of effect is consistent and well-replicated, the magnitude is modest.
Heart rate variability and baroreflex training (Grade B). The mechanism is the best-supported part of the story. Lehrer and Gevirtz's 2014 review lays out why slow breathing near 0.1 Hz produces resonance in the cardiovascular system and documents large, persistent increases in baroreflex gain after training — a genuine trained physiological adaptation, not just a temporary relaxation response. What's less clear is how much that adaptation matters for anything beyond the psychological outcomes above.
Blood pressure and hypertension (Grade C). This is where the marketing tends to outrun the evidence. A 2024 meta-analysis pooling 20 biofeedback trials found statistically significant blood pressure reductions, but the authors themselves rated the evidence low-certainty: most trials predated 2000, none tested a modern consumer wearable, and most had unclear randomization or blinding. A prior 2010 systematic review on the same question found no convincing benefit at all. Treat any cardiovascular claim on an HRV device's packaging as unproven, not disproven.
How to use it
Most supporting trials used 10-20 minutes of daily practice — slow, paced breathing at an individually tuned resonance frequency, guided by real-time feedback — for 4-6 weeks before measuring outcomes. This is a trained skill that builds over weeks, not something that produces a lasting effect after one session, even though most apps will show you a calmer heart rhythm within minutes of starting.
Safety & interactions
The intervention itself is slow breathing paired with a heart-rate display, so there's essentially no safety downside. The caveats are about accuracy and scope, not harm: consumer ear-clip and wrist sensors are less precise than the chest-strap ECG used in most of the research, and this is a stress-management tool, not a substitute for treating a diagnosed anxiety disorder or cardiovascular condition. This is informational, not medical advice — check with a clinician before starting, especially if you're managing a diagnosed condition.
How we picked the brand
An HRV biofeedback device earns a spot when its sensor technology matches what's actually used in the published research (PPG ear-clip or chest-strap ECG, not just wrist-based estimates), it includes a real-time resonance-frequency breath pacer rather than just a raw HRV number, and the company has a track record and support history rather than being a one-off crowdfunded gadget.